Inflammatory and Organ Injury Signatures Associated with Progression to Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Hospitalized Patients with COVID-19
Entzündungs- und Organschadenssignaturen bei der Progression zu mechanischer Beatmung und ECMO bei hospitalisierten Patient:innen mit COVID-19
Medical Sciences · 02.11.2026 · 14 (7) · 740
DOI: 10.3390/medsci14070740 ↗Auf einen Blick
Bei 106 hospitalisierten Patient:innen mit COVID-19 waren bestimmte Entzündungs- und Organschadensmarker mit der Eskalation der Atemunterstützung bis zur ECMO assoziiert.
Fragestellung
Sind dynamische Biomarker-Veränderungen mit der Eskalation der respiratorischen Unterstützung und nachfolgendem Endorganschaden bei hospitalisierten COVID-19-Patient:innen assoziiert?
Methode
106 PCR-bestätigte COVID-19-Patient:innen; serielle Blutproben zu 24 h, 48 h, 7 Tagen und nach 28 Tagen; Vergleich nach Atemunterstützung: keine invasive Beatmung, invasive Beatmung, ECMO.
Ergebnisse
GrECMO war mit Leukozytose, erhöhtem BLC, CRP, PCT und MCP-3 sowie selektiv erhöhtem IL6 und MUC-16 assoziiert. ECMO-Progression war mit erhöhtem MCP-4, MUC-16, TIE2 und erniedrigtem PDL2/PTN verbunden.
Schlussfolgerung der Autor:innen
Der Übergang von invasiver Beatmung zu ECMO war mit Leukozytose, erhöhtem MCP-4, TIE2 und MUC-16 sowie erniedrigtem PDL2/PTN assoziiert und deutet auf eine Verschlechterung durch multisystemischen Stress hin.
Kernaussagen
- 106 hospitalisierte Patient:innen mit PCR-bestätigter COVID-19
- Bestimmte Entzündungsmarker waren bei ECMO erhöht
- Keine Unterschiede bei Gerinnungs- oder Komplementmarkern
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 02.11.2026. Verfasst von Dandan Zhu und 3 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH NIGMS award.
Themen: Beatmung und Weaning
Abstract (Originalsprache)
Background
ECMO is used in patients with refractory cardiopulmonary failure when conventional therapy fails; however, biomarker features associated with this clinical deterioration remain unclear. We investigated whether dynamic biomarker changes were associated with the escalation of respiratory support and subsequent end-organ injury in hospitalized patients with COVID-19.
Methods
A total of 106 hospitalized patients with PCR-confirmed COVID-19 underwent serial blood sampling within 24 h (T1), 48 h (T2), 7 days (T3), and after 28 days (T4) when available. The patients were classified by respiratory support trajectory: no invasive mechanical ventilation (GrMin), invasive mechanical ventilation (GrMV), and ECMO (GrECMO). Plasma and urine inflammatory markers were profiled, together with selected coagulation, complement, neurological, and cardiovascular injury biomarkers. Clinical characteristics, severity scores, complications, and mortality were extracted from electronic records.
Results
The patients in GrECMO were younger than those in GrMin and GrMV. The SOFA and APACHE scores were lowest in GrMin and similar between GrMV and GrECMO, while GCS was lower in GrECMO. GrECMO showed leukocytosis and elevated BLC, with increased CRP, PCT, and MCP-3 in both GrMV and GrECMO versus GrMin. IL6 and MUC-16 were selectively elevated in GrECMO, whereas PDL2 and PTN were reduced and MCP-4 increased; CAIX and TREM2 were elevated in GrMV. NCAM1 levels were numerically lower, whereas pTau181 levels were higher in GrECMO than in GrMin. Progression to ECMO was associated with leukocytosis, increased MCP-4, MUC-16, and TIE2, and reduced PDL2/PTN, while early elevations of HMGB1, CRP, PCT, and TREM2 were associated with the GrMin→MV trajectory. No differences were observed in coagulation or complement markers. Six-month mortality was higher in the MV and ECMO groups, and six-month stroke incidence was highest in the GrECMO group.
Conclusions
The transition from MV to ECMO was associated with leukocytosis, increased MCP-4, TIE2, and MUC-16, and reduced PDL2/PTN, suggesting deterioration from profound multisystem stress, beyond an acute inflammatory surge.
Förderung
- NIH NIGMS award
Zitieren
APA
Zhu, D., Diedrich, D., Chen, J., & Laudanski, K. (2026). Inflammatory and Organ Injury Signatures Associated with Progression to Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Hospitalized Patients with COVID-19. Medical Sciences, 14(7), 740. https://doi.org/10.3390/medsci14070740
Vancouver
Zhu D, Diedrich D, Chen J, Laudanski K. Inflammatory and Organ Injury Signatures Associated with Progression to Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Hospitalized Patients with COVID-19. Medical Sciences. 2026;14(7):740. doi:10.3390/medsci14070740
BibTeX
@article{Zhu2026,
author = {Zhu, Dandan and Diedrich, Daniel and Chen, Jing and Laudanski, Krzysztof},
title = {Inflammatory and Organ Injury Signatures Associated with Progression to Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Hospitalized Patients with COVID-19},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {7},
pages = {740},
doi = {10.3390/medsci14070740}
}
EUVIMED